Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET
暂无分享,去创建一个
P. Angelberger | I. Virgolini | R. Dudczak | T. Traub-Weidinger | Shuren Li | F. Andreae | M. Leimer | M. Rodrigues